Special Advertising

Lpath Inc. (LPTN) Stock Quote

Detailed Quote for Lpath Inc. (LPTN)
$ 2.90   0.10 (+3.57%) Volume: 179.3k 3:59 PM EST Dec 17, 2014
Today 5d 1m 3m 1y more
Last Price
2.90
Change $
0.10
Change %
3.57%
Tick
N/A
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
2.87
High
2.91
Low
2.76
Prev Close
2.80
Last Trade
12/17/14
Volume
179.3k
52 Wk Hi
5.30
52 Wk Low
2.30
Market Cap
55.91m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
19,277,600
EPS (TTM)
-0.77
PE Ratio
N/A
Exchange
NSC
News and Media for Lpath Inc. (LPTN)
Sector News | Topic News
News for Lpath Inc. (LPTN)
Tue, Dec 02, 2014
4:05 PM Lpath Completes Enrollment in its Phase 2 Clinical Trial of iSONEP for Wet Age-Related Macular Degeneration - PR Newswire
Tue, Nov 04, 2014
4:30 PM Lpath Announces Departure Of CEO - PR Newswire
Mon, Oct 20, 2014
8:00 AM Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs - PR Newswire
Mon, Sep 29, 2014
8:30 AM Lpath, Inc. Announces Closing of $12.5 Million Registered Direct Offering - PR Newswire
Thu, Sep 25, 2014
4:05 PM Lpath to Present at the 13th Annual BIO Investor Forum - PR Newswire
Fri, Sep 19, 2014
8:30 AM Lpath, Inc. Announces $12.5 Million Registered Direct Offering - PR Newswire
Mon, Aug 11, 2014
8:00 AM Lpath to Present at 34th Annual Canaccord Genuity Growth Conference - PR Newswire
Thu, Jul 24, 2014
8:00 AM Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP - PR Newswire
Tue, May 27, 2014
9:52 PM Is Lpath Inc. a Savior from Blindness? - Equities.com
Thu, Oct 17, 2013
8:52 AM Five Star Equities Issues New Research Reports on ARIA, CGIX, CYTR and LPTN - Accesswire
Thu, Mar 01, 2012
7:19 AM Keeping an eye on Lpath as shares look to build momentum - Accesswire
Tue, Dec 06, 2011
11:13 AM Set to move: Three micro-cap stocks that analysts and instituional investors like - Accesswire
11:06 AM Set to move: Three micro-cap stocks that analysts and instituional investors like - Accesswire
Thu, Dec 01, 2011
2:11 PM Lipid Signaling program makes Lpath Inc. intriguing to Big Pharma - Accesswire
2:10 PM Lipid Signaling program makes Lpath Inc. intriguing to Big Pharma - Accesswire
More News for LPTN >>

Tags for Lpath Inc.

Research stocks or mutual funds related to Lpath Inc. by keywords or tags. Find companies that have a similar focus to LPTN. The keywords below have been associated to LPTN by either user submission or electronic means.

microcurrent macular degeneration clinical trials database human monoclonal antibody clinical research trial clinical development clinical cost antibody protein clinical pharmacology cv therapeutics stock clinical research consulting outsourcing clinical trials angiogenesis inhibitors Biological Products corporate governance clinical investigators cra clinical research cv therapeutics clinical research clinical research investigators board of directors role clinical trials manager board of directors governance board compensation antibodies directors duties board governance human antibodies Drugs monospecific antibodies pain therapeutics cardiology clinical trials clinical trials conference board of directors info medical device clinical trial cedra clinical research board of directors compensation board of directors responsibility cellegy pharmaceuticals international clinical trials board responsibilities clinical data medical trials monoclonal antibody Healthcare corporate governance board of directors monitoring clinical research clinical research guidelines clinical outsourcing clinical research investigator monospecific antibody